183 related articles for article (PubMed ID: 10389292)
1. Detection of IgA against Epstein-Barr virus BZLF-1 replication activator (ZEBRA) in sera of nasopharyngeal carcinoma patients with a recombinant ZEBRA protein.
Shu CH; Tu TY; Lin LS; Ro LH; Lo MS; Huang CH; Chen KY; Liu WT
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):350-5. PubMed ID: 10389292
[TBL] [Abstract][Full Text] [Related]
2. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
[TBL] [Abstract][Full Text] [Related]
3. Use of recombinant Epstein-Barr virus early antigen for detection of antibody in patients with nasopharyngeal carcinoma.
Liu MT; Lin LS; Yu Y; Chung TT; Hsu CY; Chen JT; Jeng KC
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):7-15. PubMed ID: 8820030
[TBL] [Abstract][Full Text] [Related]
4. Antibody response to Epstein-Barr virus Rta protein in patients with nasopharyngeal carcinoma: a new serologic parameter for diagnosis.
Feng P; Chan SH; Soo MY; Liu D; Guan M; Ren EC; Hu H
Cancer; 2001 Oct; 92(7):1872-80. PubMed ID: 11745260
[TBL] [Abstract][Full Text] [Related]
5. A high incidence of serum IgG antibodies to the Epstein-Barr virus replication activator protein in nasopharyngeal carcinoma.
Mathew A; Cheng HM; Sam CK; Joab I; Prasad U; Cochet C
Cancer Immunol Immunother; 1994 Jan; 38(1):68-70. PubMed ID: 8299121
[TBL] [Abstract][Full Text] [Related]
6. A possible prognostic role of immunoglobulin-G antibody against recombinant Epstein-Barr virus BZLF-1 transactivator protein ZEBRA in patients with nasopharyngeal carcinoma.
Yip TT; Ngan RK; Lau WH; Poon YF; Joab I; Cochet C; Cheng AK
Cancer; 1994 Nov; 74(9):2414-24. PubMed ID: 7922994
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: complementary test of ZEBRA protein and early antigens p54 and p138.
Dardari R; Hinderer W; Lang D; Benider A; El Gueddari B; Joab I; Benslimane A; Khyatti M
J Clin Microbiol; 2001 Sep; 39(9):3164-70. PubMed ID: 11526145
[TBL] [Abstract][Full Text] [Related]
8. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
[TBL] [Abstract][Full Text] [Related]
9. Study on sero-diagnosis of nasopharyngeal carcinoma using a dual antibody test against recombinant Epstein-Barr virus antigens.
Gu YL; Zhang CQ; Ng SP; Zong YS; Liang YJ; Chen YL
Ai Zheng; 2003 Sep; 22(9):903-6. PubMed ID: 12969518
[TBL] [Abstract][Full Text] [Related]
10. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
11. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
[TBL] [Abstract][Full Text] [Related]
12. The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopes.
Tedeschi R; Foong YT; Cheng HM; dePaoli P; Lehtinen T; Elfborg T; Dillner J
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1393-400. PubMed ID: 7540196
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma.
Dardari R; Khyatti M; Benider A; Jouhadi H; Kahlain A; Cochet C; Mansouri A; El Gueddari B; Benslimane A; Joab I
Int J Cancer; 2000 Apr; 86(1):71-5. PubMed ID: 10728597
[TBL] [Abstract][Full Text] [Related]
14. Detection and analysis of anti-latent membrane protein 2A antibodies in the sera of patients with Epstein-Barr virus associated malignancies.
Chen Y; Yao K; Sun H; Qing J; Peng GY
Chin Med J (Engl); 2005 May; 118(9):725-30. PubMed ID: 15899133
[TBL] [Abstract][Full Text] [Related]
15. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.
Chan KH; Gu YL; Ng F; Ng PS; Seto WH; Sham JS; Chua D; Wei W; Chen YL; Luk W; Zong YS; Ng MH
Int J Cancer; 2003 Jul; 105(5):706-9. PubMed ID: 12740922
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.
Chen H; Chi P; Wang W; Li L; Luo Y; Fu J; Zhang L; Liu W
Int J Infect Dis; 2014 Aug; 25():110-5. PubMed ID: 24878579
[TBL] [Abstract][Full Text] [Related]
17. Linear epitopes of the replication-activator protein of Epstein-Barr virus recognised by specific serum IgG in nasopharyngeal carcinoma.
Cheng HM; Foong YT; AbuSamah AJ; Dillner J; Sam CK; Prasad U
Cancer Immunol Immunother; 1995 Apr; 40(4):251-6. PubMed ID: 7750123
[TBL] [Abstract][Full Text] [Related]
18. [Early diagnosis of nasopharyngeal carcinoma using recombinant antigens expressed in bacteria].
Wan Z; Pi G; Sun N
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):74-6. PubMed ID: 12515179
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of antibodies to the Epstein-Barr virus immediate early gene product ZEBRA by a new enzyme-linked immunosorbent assay.
Yamauchi Y; Tachiband Y; Maeda A; Wakiguchi H; Usui M; Kurata T; Sairenji T
Intervirology; 1998; 41(6):278-84. PubMed ID: 10325538
[TBL] [Abstract][Full Text] [Related]
20. Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients.
Hoebe EK; Hutajulu SH; van Beek J; Stevens SJ; Paramita DK; Greijer AE; Middeldorp JM
Clin Vaccine Immunol; 2011 Feb; 18(2):298-304. PubMed ID: 21123521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
